Crossmark

Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model

Crossref DOI link: https://doi.org/10.1007/s00262-016-1950-2

Published Online: 2017-01-10

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leung, Joanne

St-Onge, Philippe

Stagg, John

Suh, Woong-Kyung https://orcid.org/0000-0002-6420-3283
Funding

Funding for this research was provided by:

Canadian Cancer Society (702047)

Canadian Institutes of Health Research (243998)
License Information

License valid from 2017-01-10